Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tulco is a private investment holding company founded by Thomas Tull that leverages a proprietary artificial intelligence and data science platform to scale high-growth companies. The firm operates through a unique model, combining permanent capital with an in-house team of data scientists known as Tulco Labs to provide deep operational support to its portfolio. Tulco maintains a significant focus on the healthcare and life sciences sectors, with major investments in companies such as Roivant Sciences and Acelyrin. By applying advanced analytics and machine learning to traditional industries, Tulco aims to drive efficiency and innovation across its diverse range of partner businesses. The company is headquartered in Pittsburgh and serves as a strategic partner to businesses ripe for technological disruption.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tulco.